Syreon Research Institute was represented in the ISPOR 19th Annual International Meeting in Montreal

Syreon Research Institute was represented in the ISPOR 19th Annual International Meeting in Montreal. Zoltan Kalo, CEO of Syreon participated in an Issue Panel (Austerity measures versus early access to innovative treatment: how to strike a balance between patients' needs and budget availabilities?), and four posters were presented on the following topics:

• Cost-effectiveness of the introduction of a risk stratified population screening for type 2 diabetes in Hungary
• The humanistic and economic burden of bulimia nervosa and binge eating disorder: a systematic literature review
• The long-term economic value of a new-born child comparison of the human capital and the lifetime investment approaches
• Transferability of international evidence on the benefits of innovative medicines into Central Eastern European countries